When O2 Health launched, in July this year, a key aim for the business was to affect positive change across the NHS which puts patients at the centre of their care. This would be achieved by forming genuine relationships with healthcare providers to gain a deep understanding of their challenges – before deploying bespoke solutions that create benefits for patients and health workers alike.
Only four months on, NHS Western Isles, Berkshire East Community Health Services and NHS Rotherham are the first health organisations announced as part of a Centre of Excellence programme focused on developing new and innovative healthcare systems.
Each health organisation will provide clinical resources and health expertise to shape new solutions being developed for a range of care settings, and pilot these to create regional centres promoting clinician-led service transformation.
Over the coming years, O2 Health will invest significantly in UK health innovation, not just mobile, and plans to channel resources through its Centre of Excellence partners in the form of managed pilots, technical expertise and forums to encourage shared learning.
Keith Nurcombe, Head of O2 Health said: ‘NHS Western Isles, Berkshire East Community Health Services and NHS Rotherham have all shown a real appetite to embrace innovation to drive better patient experiences. The Centre of Excellence programme is an industry first ‘ it gives us a great opportunity to learn directly from clinical teams. We plan to expand the programme over the next few years to other like-minded health organisations.’
NHS Western Isles Medical Director, Dr Jim Ward said: ‘We are committed to delivering high quality healthcare to people living in a remote island setting. Improved organisation of care supported by technology, combined with training for our teams will result in a service delivered more efficiently and effectively, with more time for patient care. The O2 Health team have shown a real commitment to our relationship to date. They have demonstrated a depth of understanding that could only have been achieved through detailed engagement with our clinical teams.’